ClinicalTrialsFinder
RecruitingNot ApplicableNCT07000604

Effect of ınhaler Use on Oral Health in COPD Patients

Effect of Inhaler Medication Use on Oral Health in COPD Patients: A Randomized Controlled Trial

Sponsor

Çankırı Karatekin University

Enrollment

80 participants

Start Date

May 30, 2025

Study Type

INTERVENTIONAL

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Summary

The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.

Eligibility

Min Age: 35 YearsMax Age: 80 Years

Inclusion Criteria8

  • Diagnosed with COPD for at least 6 months,
  • Outpatient and inpatient,
  • Consent to participate in the research,
  • Not under the age of eighteen,
  • With a metered dose inhaler (MDI) in treatment,
  • No communication barriers,
  • No COPD exacerbation and/or respiratory tract infection,
  • According to the GOLD report; mild (Stage 1), moderate (Stage 2), severe (Stage 3).

Exclusion Criteria7

  • Diagnosed with COPD for less than 6 months,
  • Refused to participate in the research,
  • Treatment without metered dose inhalers (MDIs),
  • Uncommunicative,
  • Those who withdrew from participating in the study during data collection,
  • Not completing the survey,
  • COPD exacerbation and/or respiratory tract infection,

Interventions

OTHERMouth Care Training

Patients will be educated on how to care for their mouths after using inhaled medication.

Locations(1)

Çankiri Devlet Hastanesi

Çankırı, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07000604

Related Trials

IMPACT COPD Cohort (China)

NCT073829864 locations

Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

NCT0689221014 locations

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

NCT07082738363 locations

Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

NCT0738071120 locations

Study of Patient With Frequent Exacerbations in Moscow

NCT073077811 location